OriGene Logo
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Support Citations

ORF Clones Citations

Browse citations based on alphabetical listing:

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |

  Page: 1 of 3 


OBFC1 Stn1 is critical for telomere maintenance and long-term viability of somatic human cells, Boccardi, V;Razdan, N;Kaplunov, J;Mundra, JJ;Kimura, M;Aviv, A;Herbig, U;, Aging Cell Feb 2015 RC200778

OCLN Long Noncoding RNA SPRY4-IT1 Regulates Intestinal Epithelial Barrier Function by Modulating the Expression Levels of Tight Junction Proteins, Xiao, L;Rao, JN;Cao, S;Liu, L;Chung, HK;Zhang, Y;Zhang, J;Liu, Y;Gorospe, M;Wang, JY;, Mol. Biol. Cell Dec 2015 RC206468

OCLN Occludin controls HIV transcription in brain pericytes via regulation of SIRT-1 activation, Castro, V;Bertrand, L;Luethen, M;Dabrowski, S;Lombardi, J;Morgan, L;Sharova, N;Stevenson, M;Blasig, IE;Toborek, M;, FASEB J. Nov 2015 RC206468

OCT1 OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer, Jeong, SH;Lee, YJ;Cho, BI;Ha, WS;Choi, SK;Jung, EJ;Ju, YT;Jeong, CY;Ko, GH;Yoo, J;Hong, SC;, Tumour Biol. Feb 2014 RC208599

OCT4 The RNA-binding protein Musashi 1 stabilizes the onco tachykinin 1 mRNA in breast cancer cells to promote cell growth, Nahas, GR;Murthy, RG;Patel, SA;Ganta, T;Greco, SJ;Rameshwar, P;, FASEB J. Sep 2015 RC211998

ODAM ODAM inhibits RhoA-dependent invasion in breast cancer, Lee, HK;Choung, HW;Yang, YI;Yoon, HJ;Park, IA;Park, JC;, Cell Biochem. Funct. Sep 2015 RC218743

ODZ1 ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA, Talamillo, A;Grande, L;Ruiz-Ontañon, P;Velasquez, C;Mollinedo, P;Torices, S;Sanchez-Gomez, P;Aznar, A;Esparis-Ogando, A;Lopez-Lopez, C;Lafita, C;Berciano, MT;Montero, JA;Vazquez-Barquero, A;Segura, V;Villagra, NT;Pandiella, A;Lafarga, M;Leon, J;Martinez-Climent, JA;Sanz-Moreno, V;Fernandez-Luna, JL;, Oncogene 2016 RC229086

OFD1 Abnormal glycosylation in Joubert syndrome type 10, Kane, MS;Davids, M;Bond, MR;Adams, CJ;Grout, ME;Phelps, IG;O'Day, DR;Dempsey, JC;Li, X;Golas, G;Vezina, G;Gunay-Aygun, M;Hanover, JA;Doherty, D;He, M;Malicdan, MC;Gahl, WA;Boerkoel, CF;, Cilia 2017 RC220154

OGDH2 Hypoxic Regulation of Glutamine Metabolism through HIF1 and SIAH2 Supports Lipid Synthesis that Is Necessary for Tumor Growth, Sun, RC;Denko, NC;, Cell Metab., Feb 2014. RC224183

OGDHL Targeted exome sequencing of Krebs cycle genes reveals candidate cancer predisposing mutations in pheochromocytomas and paragangliomas, Remacha, L;Comino-Méndez, I;Richter, S;Contreras, L;Currás-Freixes, M;Pita, G;Letón, R;Galarreta, A;Torres-Pérez, R;Honrado, E;Jiménez, S;Maestre, L;Moran, S;Esteller, M;Satrústegui, J;Eisenhofer, G;Robledo, M;Cascon, A;, Clin. Cancer Res. 2017 RC205225

OGT The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis, Zhang, X;Qiao, Y;Wu, Q;Chen, Y;Zou, S;Liu, X;Zhu, G;Zhao, Y;Chen, Y;Yu, Y;Pan, Q;Wang, J;Sun, F;, Nat Commun 2017 RC224481L1

OGT Reciprocal regulation between O-GlcNAcylation and tribbles pseudokinase 2 (TRIB2) maintains transformative phenotypes in liver cancer cells, Yao, B;Xu, Y;Wang, J;Qiao, Y;Zhang, Y;Zhang, X;Chen, Y;Wu, Q;Zhao, Y;Zhu, G;Sun, F;Li, Z;Yuan, H;, Cell. Signal. 2016 MR211521L1

OLFM2 Olfactomedin 2: Expression in the Eye and Interaction with Other Olfactomedin Domain–Containing Proteins, Afia Sultana, Naoki Nakaya, Vladimir V. Senatorov, and Stanislav I. Tomarev, Invest. Ophthalmol. Vis. Sci., Apr 2011; 52: 2584 - 2592 RC203786

OLFM4 Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway, Li, H;Liu, W;Chen, W;Zhu, J;Deng, CX;Rodgers, GP;, Sci Rep Nov 2015 RG214942

OLFR78 Oxygen regulation of breathing through an olfactory receptor activated by lactate, Chang, AJ;Ortega, FE;Riegler, J;Madison, DV;Krasnow, MA;, Nature Nov 2015 MR215094

OLIG1 Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development, Dai, J;Bercury, KK;Jin, W;Macklin, WB;, J. Neurosci. Dec 2015 RC229139

OLIG2 Enhancing Oligodendrocyte Differentiation by Transient Transcription Activation via DNA Nanoparticle-Mediated Transfection, Li, X;Tzeng, SY;Zamboni, CG;Koliatsos, VE;Ming, GL;Green, JJ;Mao, HQ;, Acta Biomater 2017 RG208209

OLIG2 Nanoparticle-mediated conversion of primary human astrocytes into neurons and oligodendrocytes, Li, X;Kozielski, K;Cheng, YH;Liu, H;Zamboni, CG;, Biomater. Sci. Jun 2016 RG208209

OMA1 The Role and Regulation of Mitochondrial Dynamics in Cisplatin Resistance in Human Gynecologic Cancer Cells, Kong, B;, Thesis Jun 2015 RC204507

OMA1 p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in Gynecologic Cancers, Kong, B;Wang, Q;Fung, E;Xue, K;Tsang, BK;, J. Biol. Chem. Aug 2014 RC204507

 

Inc 5000 Healthcare Company